Dr. Jennifer McVean, MD, stands at the forefront of pediatric endocrinology, dedicating her career to enhancing the lives of children and families affected by diabetes and endocrine disorders. Diagnosed with Type 1 diabetes at the age of 11, Dr. McVean brings a unique perspective to her practice, blending personal experience with professional expertise to offer compassionate and innovative care.
Currently serving as the Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean has been instrumental in advancing diabetes technology and treatment protocols. Her work focuses on developing and promoting automated insulin delivery systems, such as the MiniMed™ 780G system, which have shown significant improvements in glycemic control and quality of life for pediatric patients. A recent study highlighted that the MiniMed™ 780G system reduces the burden of diabetes management by improving sleep and overnight glycemic control, underscoring the impact of Dr. McVean’s contributions to the field.
Dr. McVean’s academic journey includes earning her medical degree from the University of Minnesota Medical School, completing her pediatric residency at the University of Colorado, and a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in both Pediatrics and Pediatric Endocrinology. Her professional tenure encompasses roles at esteemed institutions such as the University of Minnesota, Children’s Minnesota, and Gundersen Health System, where she has been pivotal in clinical practice, research, and education.
Beyond her clinical and research endeavors, Dr. McVean is deeply involved in diabetes advocacy and education. She has collaborated with organizations like the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association (ADA), contributing to community outreach programs and mentoring initiatives aimed at improving diabetes awareness and treatment.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
For more information about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.